A new resource rating >50,000 foods from 3 grocery stores (@Walmart, @Target, @WholeFoods) for degree of processing and breakdown of ingredients
Thanks to @menicgiulia @BabakRavandi @BarabasiLab and colleagues
https://t.co/DsTPF5rqdH
Last year, M&A ended with about $80B in #biotech buyouts. This morning, we're up to $18 billion and counting. That's a clear indication that the first year of Trump 2.0 is going to be significantly more active than 2024. $LLY $JNJ $GSK. When do we hear from $BMY?
https://t.co/XrtyZrU49u
Digitizing the human proteome in >53,000 individuals with 15-year follow-up and, with machine learning, unraveling nearly 500 disease-causing proteins
https://t.co/VsYD6vG07R @CellCellPress
UCB was pleased to host HRH Princess Astrid and the Belgian Delegation at our Atlanta headquarters today to inaugurate our new 70,000 sqft inspace facility. We’re proud of the impact of our commitment to patients, the community, and long-term sustainable growth. #BEmissionUSA
@JNys86 from @byteflies & I were recording last night; talking seriously about #epilepsy research & the need for seizure-detection devices such as @byteflies' EpiCare@Home. This'll be the final release of 2021 (30th Dec)!
Pdcst: https://t.co/RqiKGhuPAT
YT: https://t.co/JOewJHPDGr
EpiCare@Home will be present at the AES conference in Chicago from Dec. 3 - 7!
Come by booth 1836 and we’ll showcase how we enable faster #epilepsy care by facilitating long-term home #monitoring, all with the aim of alleviating the burden on those affected by epilepsy.
You can watch the lectures of the 3rd International Congress on Mobile Devices and Seizure Detection in Epilepsy.
Use this link, & then click on the name of the speaker, to start the video:
https://t.co/qkmd4rszP5
The access is free & will be available until April 1st, 2022.
While there have been significant developments in #epilepsycare, more can be done to holistically manage the disease. We spoke to @byteflies on their opinions of the greatest challenges faced by people living with #epilepsy.